Literature DB >> 24344191

Family history of premature cardiovascular disease: blood pressure control and long-term mortality outcomes in hypertensive patients.

Catherine Williamson1, Panniyammakal Jeemon, Claire E Hastie, Linsay McCallum, Scott Muir, Jesse Dawson, Matthew Walters, William Sloan, David Morrison, Anna F Dominiczak, Jill Pell, Sandosh Padmanabhan.   

Abstract

AIMS: Current guidelines recommend early referral and initiation of intensive cardiovascular (CV) risk reduction in individuals with a positive family history of coronary heart disease (CHD). We hypothesized that a family history of premature CHD and stroke [CV disease (CVD)] would lead to earlier referral of hypertensive patients to secondary care clinic, leading to better control of risk factors, mitigating the excess risk seen in these individuals. METHODS AND
RESULTS: We studied the association of a positive family history of CVD in 10 787 individuals with longitudinal changes in risk factors and long-term cause-specific mortality in the Glasgow Blood Pressure Clinic using generalized estimating equations and the Cox proportional hazard models, respectively. The total time at risk was 193 756 person-years with a median survival time of 29.2 years. A positive family history of CVD was associated with an earlier presentation to the clinic, a lower burden of traditional CV risk factors, and similar longitudinal blood pressure reduction and drug adherence compared with those without. But despite these positive features, all-cause [hazard ratio (HR) = 1.12, 95% confidence interval 1.01-1.25] and CV (HR = 1.20, 1.04-1.38) mortality independent of baseline risk factors were worse. Consistent results were observed in propensity score-matched analysis. Inclusion of family history of CVD did not improve mortality risk discrimination over and above traditional risk factors.
CONCLUSION: Our study suggests that despite earlier referral and treatment of individuals with a positive family history of premature CVD, excess risk persists, indicating the need for continued and sustained efforts to reduce risk factors and drug adherence in these individuals.

Entities:  

Keywords:  Epidemiology; Family history; Hypertension; Mortality

Mesh:

Substances:

Year:  2013        PMID: 24344191     DOI: 10.1093/eurheartj/eht539

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  9 in total

1.  Significance of preoperative left ventricular ejection fraction in 5-year outcome after isolated CABG.

Authors:  Aida Fallahzadeh; Ali Sheikhy; Ali Ajam; Saeed Sadeghian; Mina Pashang; Mahmoud Shirzad; Jamshid Bagheri; Soheil Mansourian; Shahram Momtahen; Kaveh Hosseini
Journal:  J Cardiothorac Surg       Date:  2021-12-27       Impact factor: 1.637

2.  Impact of family history of coronary artery disease on in-hospital clinical outcomes in ST-segment myocardial infarction.

Authors:  Manyoo A Agarwal; Lohit Garg; Carl J Lavie; Guy L Reed; Rami N Khouzam
Journal:  Ann Transl Med       Date:  2018-01

3.  Longitudinal Blood Pressure Control, Long-Term Mortality, and Predictive Utility of Serum Liver Enzymes and Bilirubin in Hypertensive Patients.

Authors:  Linsay McCallum; Jeemon Panniyammakal; Claire E Hastie; Jonathan Hewitt; Rajan Patel; Gregory C Jones; Scott Muir; Matthew Walters; Naveed Sattar; Anna F Dominiczak; Sandosh Padmanabhan
Journal:  Hypertension       Date:  2015-05-04       Impact factor: 10.190

4.  Association of Family History With Cardiovascular Disease in Hypertensive Individuals in a Multiethnic Population.

Authors:  Luca Valerio; Ron J Peters; Aeilko H Zwinderman; Sara-Joan Pinto-Sietsma
Journal:  J Am Heart Assoc       Date:  2016-12-21       Impact factor: 5.501

5.  A PROgramme of Lifestyle Intervention in Families for Cardiovascular risk reduction (PROLIFIC Study): design and rationale of a family based randomized controlled trial in individuals with family history of premature coronary heart disease.

Authors:  Panniyammakal Jeemon; S Harikrishnan; G Sanjay; Sivasankaran Sivasubramonian; T R Lekha; Sandosh Padmanabhan; Nikhil Tandon; Dorairaj Prabhakaran
Journal:  BMC Public Health       Date:  2017-01-05       Impact factor: 3.295

6.  Prognostic significance of positive family history in outcomes after coronary artery bypass grafting: Do we need to update our assumptions?

Authors:  Hamed Tavolinejad; Sina Rashedi; Seyyed Mojtaba Ghorashi; Masih Tajdini; Saeed Sadeghian; Mina Pashang; Arash Jalali; Abbas Salehi Omran; Jamshid Bagheri; Abbasali Karimi; Mahmoud Shirzad; Mehdi Mehrani; Kaveh Hosseini
Journal:  J Cardiothorac Surg       Date:  2022-04-27       Impact factor: 1.522

7.  Contrasting mortality risks among subgroups of treated hypertensive patients developing new-onset diabetes.

Authors:  Stefanie Lip; Panniyammakal Jeemon; Linsay McCallum; Anna F Dominiczak; Gordon T McInnes; Sandosh Padmanabhan
Journal:  Eur Heart J       Date:  2015-10-27       Impact factor: 29.983

8.  Cardiac, Macro-, and Micro-Circulatory Abnormalities in Association With Individual Metabolic Syndrome Component: The Northern Shanghai Study.

Authors:  Fang Zhao; Rong Yang; Rusitanmujiang Maimaitiaili; Jiamin Tang; Song Zhao; Jing Xiong; Jiadela Teliewubai; Chen Chi; Jacques Blacher; Jue Li; Yawei Xu; Yan Jiang; Yi Zhang; Weiming Li
Journal:  Front Cardiovasc Med       Date:  2021-07-09

9.  Associations of Blood Pressure with the Factors among Adults in Jilin Province: A Cross-Sectional Study Using Quantile Regression Analysis.

Authors:  Junsen Ye; Zhongmin Li; Yaogai Lv; Lan An; Jianxing Yu; Xin Guo; Yan Yao; Yaqin Yu; Lina Jin
Journal:  Sci Rep       Date:  2017-10-19       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.